GDGabrielle Deveber

Gabrielle Deveber

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Gabrielle Deveber has a total of 9 co-authors. Here are the top co-authors by number of shared publications:

  • Ann-Marie Pontigon

    From the Section of Neurology (M.F.R.), Department of Pediatrics and Child Health, University of Manitoba, the Population Health Sciences Program (M.F.R., A.-M.P., J.C., M.A., G.A.d.V.), the Division of Emergency Medicine (D.A.J.), and the Division of Neurology (D.M., G.A.d.V.), The Hospital for Sick Children, Toronto, Ontario, Canada; and the Division of Neurology (F.S.), University Health Network, Toronto, Ontario, Canada

    1 shared publication
  • D. Anna Jarvis

    From the Section of Neurology (M.F.R.), Department of Pediatrics and Child Health, University of Manitoba, the Population Health Sciences Program (M.F.R., A.-M.P., J.C., M.A., G.A.d.V.), the Division of Emergency Medicine (D.A.J.), and the Division of Neurology (D.M., G.A.d.V.), The Hospital for Sick Children, Toronto, Ontario, Canada; and the Division of Neurology (F.S.), University Health Network, Toronto, Ontario, Canada

    1 shared publication
  • Daune MacGregor

    From the Section of Neurology (M.F.R.), Department of Pediatrics and Child Health, University of Manitoba, the Population Health Sciences Program (M.F.R., A.-M.P., J.C., M.A., G.A.d.V.), the Division of Emergency Medicine (D.A.J.), and the Division of Neurology (D.M., G.A.d.V.), The Hospital for Sick Children, Toronto, Ontario, Canada; and the Division of Neurology (F.S.), University Health Network, Toronto, Ontario, Canada

    1 shared publication
  • Denis Geary

    The Hospital for Sick Children

    1 shared publication
  • Frank Silver

    From the Section of Neurology (M.F.R.), Department of Pediatrics and Child Health, University of Manitoba, the Population Health Sciences Program (M.F.R., A.-M.P., J.C., M.A., G.A.d.V.), the Division of Emergency Medicine (D.A.J.), and the Division of Neurology (D.M., G.A.d.V.), The Hospital for Sick Children, Toronto, Ontario, Canada; and the Division of Neurology (F.S.), University Health Network, Toronto, Ontario, Canada

    1 shared publication
  • Jackie Chiang

    From the Section of Neurology (M.F.R.), Department of Pediatrics and Child Health, University of Manitoba, the Population Health Sciences Program (M.F.R., A.-M.P., J.C., M.A., G.A.d.V.), the Division of Emergency Medicine (D.A.J.), and the Division of Neurology (D.M., G.A.d.V.), The Hospital for Sick Children, Toronto, Ontario, Canada; and the Division of Neurology (F.S.), University Health Network, Toronto, Ontario, Canada

    1 shared publication

Latest Publications

  • Delay to Diagnosis in Acute Pediatric Arterial Ischemic Stroke

    by Mubeen F. Rafay, Ann-Marie Pontigon, Jackie Chiang, Margaret Adams, D. Anna Jarvis, Frank Silver, Daune MacGregor, Gabrielle A. Deveber

    Background and Purpose— For the clinician, the diagnosis of arterial ischemic stroke (AIS) in children is a challenge. Prompt diagnosis of pediatric AIS within 6 hours enables stroke-specific thrombolytic and neuroprotective strategies. Methods— We conducted a retrospective study of prospectively enrolled consecutive cohort of children with AIS, admitted to The Hospital for Sick Children, Toronto, from January 1992 to December 2004. The data on clinical presentation, symptom onset, emergency department arrival, neuroimaging and stroke diagnosis were recorded. The putative predictors of delayed diagnosis were selected a priori for analysis. Results— A total of 209 children with AIS were studied. The median interval from symptom onset to AIS diagnosis was 22.7 hours (interquartile range: 7.1 to 57.7 hours), prehospital delay (symptom onset to hospital arrival) was 1.7 hours (interquartile range: 49 minutes to 8.1 hours), and the in-hospital delay (presentation to diagnosis) was 12.7 hours (interquartile range: 4.5 to 33.5 hours). The initial assessment was completed in 16 minutes and initial neuroimaging in 8.8 hours. The diagnosis of AIS was suspected on initial assessment in 79 (38%) children and the initial neuroimaging diagnosed AIS in 47%. The parent’s help seeking action, nonabrupt onset of symptoms, altered consciousness, milder stroke severity, posterior circulation infarction and lack of initial neuroimaging at a tertiary hospital were predictive delayed AIS diagnosis. Conclusion— In the diagnosis of AIS, significant prehospital and in-hospital delays exist in children. Several predictors of the delayed AIS diagnosis were identified in the present study. Efforts to target these predictors can reduce diagnostic delays and optimize the management of AIS in children.


    • 1 January 2009
      • Vol. 29  (1) , 88-90

    Paediatric stroke. Who should be treated?

    by G Deveber

    The past decade has seen a dramatic increase in pediatric stroke research. However few studies have addressed antithrombotic safety or effectiveness. Three paediatric stroke guidelines combining research data with expert consensus have been published in the past five years. For most patients treatment recommendations are consistent. Newborns with arterial ischaemic stroke (AIS) rarely require antithrombotic treatment given their extremely low risk of recurrence. In children with AIS a substantial recurrence risk means that antithrombotic treatment is required unless contraindicated. Anticoagulation (heparins, warfarin) is recommended for possible or established dissection and cardiogenic embolism. Antiplatelet treatment is recommended for other children with AIS. For neonatal cerebral sinovenous thrombosis (CSVT) most centers provide initial anticoagulation in the absence of haemorrhagic contra indications, and otherwise, monitor for propagation. Children with CSVT, even with haemorrhagic infarction, more consistently receive anticoagulation, as in adults. While more studies are necessary, current treatment guidelines offer an interim option for guiding the treatment of paediatric stroke.


  • Cerebral sinovenous thrombosis and idiopathic nephrotic syndrome in childhood: report of four new cases and review of the literature

    by Joel Fluss, Denis Geary, Gabrielle Deveber

    Nephrotic children are prone to develop thromboembolic complications secondary to an acquired hypercoagulable state. Cerebral sinovenous thrombosis (CSVT) is increasingly recognised in this population, but clinical characteristics and outcome are not well documented. The database of the Canadian Pediatric Ischemic Stroke Registry (Toronto Site) containing prospectively enrolled children from 1992–2004 with CSVT identified four children with NS. A pooled literature analysis retrieved 17 additional cases reports. CSVT presented in the majority of cases during the first flare or within 6 months after the onset of NS and was found to occur more often in SSNS/SDNS (n=13) than in SRNS (n=4). Clinical manifestations were non-specific and consisted primarily of seizures (n=8) and signs of raised intracranial pressure (n=16). Imaging studies revealed a predilection for superior sagittal sinus involvement (n=21) and rare parenchymal lesions (n=4). The most consistent biological risk factors were a severe hypoalbuminaemia (n=14) and, to a lesser extent, decreased antithrombin (AT) levels (n=9/16). Deficiency of other coagulation inhibitors (protein S, protein C) was not identified. Inherited thrombophilia was documented in a single case, suggesting that acquired, more than genetic, coagulation factors are involved. Anticoagulation was safe, and the outcome was good in most patients, and no recurrence of thrombotic event was reported. In conclusion, CSVT is now a well-described complication of NS with potential morbidity. A high index of suspicion is required, especially in young children with NS presenting neurological symptoms. Reliable biological predictors of CSVT are lacking.